Skip to main content
PLOS One logoLink to PLOS One
. 2023 Feb 22;18(2):e0277960. doi: 10.1371/journal.pone.0277960

An evaluation of trace elements and oxidative stress in patients with benign paroxysmal positional vertigo

Hüseyin Günizi 1,*,#, Hasan Basri Savaş 2,#
Editor: Donovan Anthony McGrowder3
PMCID: PMC9946263  PMID: 36812180

Abstract

Objectives

Vertigo and Dizziness are a common complaint among the reasons for applying to the ear nose throat clinic. Benign Paroxysmal Positional Vertigo (BPPV) is the most common cause of perpheric vertigo. Oxidative stress is caused by the formation of hydroxyl radicals, superoxide anions and hydrogen peroxide, which are reactive oxygen derivatives (ROS). The aim of this study is to investigate the relationship between complaints and serum trace element and oxidative stress levels in patients with BPPV.

Methods

This study was conducted with 66 adult patients who presented to the ENT policlinic with the complaint of vertigo and were diagnosed with BPPV between May 2020 and September 2020. Blood samples were taken from patients diagnosed with BPPV to measure serum Zn and Cu levels and oxidative stress levels during an attack.

Results

The mean ages of the study patients and healthy controls were 45.7 ± 15.1 and 44.7±13.2. Female / Male ratio were 28(42.5%)/38(57.5%) and 32(48.5%)/34(51.5%) in study and control group. We found serum Cu levels were lower in the patient group (p <0.05). Serum Total Thiol and Native Thiol values were lower in patients with BPPV. Total Thiol results were statistically significant.(p<0.05) Disulfide values were significantly higher in the disease group. (P <0.05). Thiol Oxidized / Thiol Reduced ratio (2243.6±6.7/343.8±125.3) was higher in control group. (p<0.05)

Conclusion

Serum oxidative stress and trace elements play a role in the pathophysiology of BPPV. We present the cut-off values for Cu and Zn in vertigo patients for the first time in the literature. We think that these cut-off values of the trace elements and thiol/disulfide hemostasis can be used clinically by physicians in the etiology, diagnosis and treatment of vertigo.

Introduction

Vertigo and Dizziness are a common complaint among the reasons for applying to the ear nose throat clinic [1]. It affects approximately 20–30% of the general population [2]. Vertigo is an acute symptom arising from the asymmetry of the vestibular system in single or recurrent attacks. Vertigo may be due to peripheral or central diseases. Benign Paroxysmal Positional Vertigo (BPPV) is the most common cause of perpheric vertigo [3]. Among the peripheral vestibular disease, the frequency of BPPV has been reported to be 25–40%. BPPV is ascribed to otoconial matter dislodged from utricular macula and attached to the cupula of the affected semicircular canal (cupulolithiasis) or free-floating within its lumen (canalolithiasis) [4,5]. In BPPV, dizziness develops due to otoliths in the posterior (85–90%) and horizontal (5–15%) canals [3].

Oxidative stress is a condition caused by an imbalance between production and accumulation of oxygen reactive species (ROS) in cells or tissues and the ability of a biological system to detoxify these reactive products. Superoxide radicals, hydrogen peroxide, hydroxyl radicals and singlet oxygen are commonly defined reactive oxygen species (ROS) [6,7]. In the tissues, high rates of oxygen utilization lead to the generation of partially reduced forms of oxygen or reactive oxygen species (ROS), which are derived from the activity of electron transport chain in mitochondria [8]. Free radicals cause oxidative cell damage and this is a situation that occurs continuously during metabolic processes. ROS and free radicals react with and damage several cellular structures such as proteins, lipids, membranes, lipoproteins, and deoxyribonucleic acid [9]. ROS react with most biomolecules, their major targets include unsaturated lipids and intracellular thiols [8]. In oxidative stress, thiol oxidizes and converts to disulfide. Thiol balance is an important and dual indicator of oxidant-antioxidant balance [10]. Prevention of oxidative damage, keeping it in balance and maintaining vitality is only possible with antioxidant activity. If this process gets out of control it can induces several chronic inflammatory diseases as rheumatoid arthritis, and degenerative, body aging process and acute pathologies as stroke [9,11].

Trace elements constitute the building blocks of enzymes, hormones and vitamins as well as metabolism support, healthy tissue formation and supporting the immune system. Zn and Cu are the trace elements that are essential and vital for the body. Zinc is an enzymatic activator and catalyst in hormonal processes and amino acid cycle. Copper is a necessary trace element in the controlled work of enzymes in biological oxidation events. The extracellular form of the superoxide dismutase enzyme, which is the only antioxidant secreted by fibroblast, glia and endothelial cells and capable of inactivating superoxide radicals enzymatically at the extracellular level, contains Cu and Zn. It has a very important role in the prevention of many diseases such as oxidant damage, inflammation and fibrosis [12]. Therefore, the antioxidant effect of Zn and Cu is remarkable.

Disruption of the balance between oxidative stress and antioxidant system plays a role in the etiopathogenesis of many diseases. There are not enough studies investigating the link between oxidative stress level, serum Zn/Cu levels and symptoms in vertigo patients. The aim of this study is to investigate the relationship between complaints and serum trace element and oxidative stress levels in patients with a diagnosis of BPPV.

Materials and methods

This study was conducted with 66 adult patients who presented to the ENT policlinic with the complaint of vertigo and were diagnosed with BPPV between May 2020 and September 2020 in Alanya Alaaddin Keykubat University Hospital. Patients with a history of Meniere’s disease, vestibular neuritis, acoustic neurinoma, sudden hearing loss, hearing loss on audiometric examination, history of head trauma, and having an otologic surgery were not included in the study. Detailed ear, nose and throat and neurological examinations of all patients were performed. An audiometric examination was performed, patients with hearing loss were excluded from the study. Dix-Hallpike and Supine Head-Roll maneuvers were performed. Epley’s and Barbecue repositioning maneuver was applied to patients who developed rotatory nystagmus during the maneuvers and supported BPPV. Among these patients, those who did not have diabetes mellitus, hyperlipidemia, etc., had normal parameters such as sedimentation and c-reactive protein in routine blood tests, and had a first BPPV attack were included in the study. Blood samples were taken from patients diagnosed with BPPV to measure serum Zn and Cu levels and oxidative stress levels during at the first attack and before 12:00 a.m. while they were fasting. The control group included 66 healthy volunteers with age and gender distribution similar to the BPPV patient group. They had no neurotologic symptoms and no history of any dizziness or imbalance.

This study was approved by the Local Ethical Committee of Alanya Alaaddin Keykubat University (Protocol Number: 18–4: Approve Date:22.04.2020). Written consent was obtained from all patients in our study.

Measurement of thiol disulfide homeostasis

Thiol / disulfide homeostasis measurements were made using the standard colorimetric method described in the literature [10]. Two separate serum samples were collected for each patient. Serum total thiol measurement was performed using standard colorimetric method and commercial kit (Rel Assay Diagnostics, Gaziantep). Ten μL sample was treated with 10μL sodium borohydride in 50% methanol-water solution (v/v; R1). 110μL 6.715mM formaldehyde and 10.0mM ethylenediaminetetraacetic acid (EDTA) in Tris buffer 100mM (pH 8.2) used for Excess reductants eliminating to determine total thiol. A 10μL sample was treated with 10μL sodium chloride in 50% methanol-water solution (v/v; R1’) and 110μL 6.715mM formaldehyde and 10.0mM EDTA in Tris buffer 100mM (pH 8.2) used to determine native thiol. Dynamic disulfide amount was calculated by taking half of the difference between the total thiol and natural thiol groups. All the chemicals were purchased from Merck Chemicals (Darmstadt, Germany) and Sigma-Aldrich Chemie (Milwaukee, Wisconsin, USA). In this way, natural and total thiols were calculated. Then serum disulfide levels and disulfide / natural thiol, disulfide / total thiol and natural / total thiol ratios were determined. Units are given as μmol/L [10].

Zinc-copper levels

Serum zinc–copper levels were measured using a standard colorimetric method and a commercial kit (Rel Assay Diagnostics, Gaziantep). Units are given as μg / dl [13,14].

Statistical analysis

The distribution of the data in the study was evaluated with ShapiroWilk’s test statistics, histogram, and q-q graph.The independent two sample t test and Mann-Whitney U test were used to compare the difference between the means of two independent groups. Bonferroni correction was not applied because we only looked at 2 parameters. Categorical variables were expressed as numbers and percentages, whereas continuous variables were summarized as mean and standard deviation or median (minumum-maximum). Roc analysis was applied for all parameters. The cut-off values, area under the curve (AUC), sensitivity and specificity were calculated using the receiver operating characteristic (ROC) curve technique for trace elements and oxidation products. Chi-square analysis was performed to determine the relationships between categorical variables. Pearson correlation analysis was performed to determine the direction and strength of the relationships between trace elements and oxidation products. Univariate binary logistics regression analysis was performed to determine the risk factors affecting BPPV. Data analysis was performed in TURCOSA Cloud (Turcosa Ltd Co, www.turcosa.com.tr) statistics software. It was accepted as the statistical significance level (p<0.05).

Results

In our study, 66 patients diagnosed with BPPV and 66 healthy control groups were examined prospectively. The mean ages of the study patients and healthy controls were 45.8 ± 15.1 and 44.8±13.2. Female / Male ratio were 28(42.5%)/38(57.5%) and 32(48.5%)/34(51.5%) in study and control group. There were 54 (82%) patients with BPPV affecting the posterior and 12(18%) patients with BPPV affecting the lateral canal. Serum Cu and Zn levels of patients with BPPV were compared with the control group. There were no statistically significant differences between male and female genders in terms of Cu and Zn levels. We found mean serum Cu levels to 119,6± 47.6 μg/dl in the patient group, and this result was lower than control group. Low Cu level was statistically significant (p <0.05) as indicated in Table 1. Serum mean zinc level was higher in study patients than control patients (87.1± 13.2 μg/dl). Serum Total Thiol (611.7±84.8/535.0±154.7)and Native Thiol (551.2±89.3/328.4±98.1) values were higher in the control group. These results were statistically significant. (P <0.05) We found high disulfide values in BPPV patients, and these results were statistically significant.(p <0.05) Reduced Thiol (89.9±4.9) level was higher in control group and Oxidized Thiol(19.3±4.1) level was higher in BPPV group.(p<0.05) Thiol Oxidized / Thiol Reduced ratio (2243.6±6.7/343.8±125.3) was higher in control group. (p<0.05) as indicated in Table 2.

Table 1. Comparison of trace elements between study groups.

Variables BPPV Control P
Age 45.8±15.1 44.8±13.2 0.692
Zn(μg/dL) 87.1±13.2 85.8 ±7.6 0.496
Cu(μg/L) 119 ± 47.6 135.7± 42.2 0.041

Zn; zinc, Cu; copper, BPPV; Benign Paroxysmal Positional Vertigo.

Table 2. Comparison of thiol, native thiol and disulphide.

BPPV
Control P
Total Thiol(μmol/l)
535.0±154.7 611.7±84.8 <0.001
Native Thiol(μmol/l)
328.5±98.1 551.2±89.3 <0.001
Disulphide (μmol/l)
104.2±41.2 30.2±13.7 <0.001
Reduced Thiol(μmol/l) 61.7±9.5 89.9±4.9 <0.001
Oxidized Thiol(μmol/l) 19.3±4.1 5.0±2.4 <0.001
Thiol Oxidation/Reduction Ratio
419.7(105.5–4459.6) 1359.6(616.1–4459.6) <0.001

Data were expressed as arithmatic mean and standard deviation or median (minumum-maximum). BPPV; Benign Paroxysmal Positional Vertigo.

ROC analysis of trace elements and oxidation products, Univariate Logistic regresson analysis, Pearson correlation matrix of trace elements and oxidation products for control group, Pearson correlation analysis of trace elements and oxidation products for control BPPV were given below as indicated in Table 3 and Fig 1, Tables 46. In the ROC analysis of Cu, Zn and Total Thiol values, the AUC values were below 0.75, so we could not evaluate these values as independent predictive factors. According to Univariate Logistic regresson analysis; Those with a serum Zn level below 81.7 μg/dL have a 2,210 fold higher risk of developing vertigo than those with an age parameter above 81.7 μg/dL.(Odds ratio: 2.210; %95 CI: 1.035–4.718, p = 0.040). Those with a serum Cu level below 104.6 μg/dL have a 2,210 fold higher risk of developing vertigo than those with an age parameter above 104.6 μg/dL.(Odds ratio: 2.968, %95 CI: 1.445–6.100 p = 0.003). The risk of developing BPPV in patients with serum NT level lower than 416.5 μmol/L was 85,615 times higher than those with serum NT level higher than 416.5 μmol/L (Odds ratio: 85.615% 95 CI:23.160–316.499 P<0.001).

Table 3. ROC analysis of trace elements and oxidation products.


Variables
AUC-ROC(%95 CI) P value Cut-off value Sensitivity Specificity +LR -LR PP NP
Zn (μg/dL) 0.508(0.419–0.596) <0.001 81.7 0.424 0.757 1.75 0.76 0.64 0.57
Cu (μg/L) 0.648(0.560–0.729) <0.001 104.6 0.591 0.712 2.05 0.57 0.67 0.64
Total Thiol(μmol/l) 0.737(0.652–0.809) <0.001 552.4 0.712 0.803 3.62 0.36 0.78 0.74
Native Thiol(μmol/l)
0.940(0.885–0.974) <0.001 416.5 0.818 0.954 18.0 0.19 0.95 0.84
Disulphide(μmol/l)
0.996(0.965–0.999) <0.001 60.4 0.969 0.984 64.0 0.03 0.99 0.97
Reduced Thiol(μmol/l) 0.984(0.945–0.998) <0.001 73.5 0.970 1.000 - 0.03 1.000 0.97
Oxidized Thiol(μmol/l) 0.999(0.971–1.000)
<0.001 13.3 0.984 1.000 - 0.02 1.00 0.99
Thiol Oxidation / Reduction Ratio 0.999(0.970–1.000) <0.001 554.4 0.970 1.000 - 0.03 1.00 0.97

AUC-ROC; area under ROC curve, PP; positive predictive value, NP; negative predictive value, 95% CI; confidence interval, +LR; positive likelihood ratio, -LR; negative likelihood ratio.

Fig 1. ROC curve of Disulfide, Native Thiol, Oxidized Thiol, Reduced Thiol and Total Thiol.

Fig 1

Table 4. Univariate Logistic regresson analsis.


Variables
Groups p Univariate Binary Logistic Regression Analysis p
Control
n(%)
BPPV
n(%)

OR

95%CI
Zn 81.7≥
81.7<
51(77.3) 40(60.6) 0.039 Reference 0.040
15(22.7) 26(39.4) 2.210 1.035–4.718
Cu 104.6≥
104.6<
47(71.2) 30(45.5) 0.003 Reference
19(28.8) 36(54.5) 2.968 1.445–6.100 0.003
Total thiol 552.4≥
552.4<
53(80.3) 20(30.3) <0.001 Reference
13(19.7) 46(69.7) 9.377 4.204–20.915 <0.001
Native Thiol 416.5≥
416.5<
63(95.5) 13(19.7) <0.001 Reference
3(4.5) 53(80.3) 85.615 23.160–316.499 <0.001
Disulphide 60.4≥
60.4<
1(1.5) 64(97.0) <0.001
65(98.5) 2(3.0) -
Reduced Thiol 73.5≥
73.5<
66(100.0) 3(4.5)
0(0.0) 63(95.5) <0.001 -
Oxidized Thiol 13.3≥
13.3<
0(0.0) 65(98.5) <0.001
66(100.0) 1(1.5) -
Thiol Oxid./Red. 554.4≥
554.4<
66(100.0) 3(4.5) <0.001
0(0.0) 63(95.5) -

Univariate Logistic regresson analsis: -; OR could not be calculated because frequencies were insufficient, 95% CI; confidence interval, OR; Odss Ratio Thiol Oxid./Red.; Thiol oxidation / reduction ratio.

Table 6. Pearson correlation matrix of trace elements and oxidation products for BPPV group.

Zn Cu
Total Thiol r = 0.5899
p = <0.001
r = 0.8719
p = <0.001
Native Thiol r = 0.5916
p = <0.001
r = 0.8734
p = <0.001
Disulfide r = 0.3857
p = 0.001
r = 0.5869
p = <0.001
Reduced Thiol r = 0.0725
p = 0.563
r = 0.1001
p = 0.424
Oxidized Thiol r = -0.1197
p = 0.338
r = -0.1351
p = 0.279
Thiol Oxidation / Reduction Ratio r = 0.0958
p = 0.444
r = 0.0946
p = 0.450

The top side of the matrix is the pearson correlation coefficient (r) and the bottom side is the significance value (p). BPPV; Benign Paroxysmal Positional Vertigo.

According to Roc analysis, the results of AUC values were Oxidized Thiol, Thiol Oxidized / Thiol Reduced ratio, Reduced Thiol, Disulfid and Native Thiol, Total Thiol, CU and Zn, in order of statistical significance. Cut-off and p values according to this order 554.4 μmol/l- p<0.001, 13.3 μmol/lp<0.001, 73.5 μmol/lp<0.001, 60.4 μmol/lp<0.001, 416.5 μmol/lp<0.001, 552.4 μmol/lp It was <0.001,104.6 μg/Lp<0.001, 81.7 μg/Lp<0.001. When the areas under the curve (AUC) were evaluated in Roc analysis, Oxidizel Thiol, Thiol Oxidized / Thiol Reduced ratio, Reduced Thiol, Disulfid and Native Thiol were found to be significantly higher.

Discussion

Researchers previously stated that oxidative stress has an effect on the etiology of hearing loss, rhinosinusitis, otitis media, chronic tonsillitis and laryngeal cancer [15,16]. There are studies explaining that the inflammatory process and oxidative stress formation play a role in the development of vertigo [17]. İn a study, researchers indicated that calcium metabolism and its relationship with oxidative stress may play a role in the development of BPPV [18].

Oxidative stress is effective in calcium metabolism. The endoplasmic reticulum is the major organelle in calcium storage and has the ability to increase calcium flux under stress. This situation increases the formation of ROS in mitochondria. Calcium influx to the mitochondria and increased oxidative stress cause rupture of the outer mitochondrial membrane and apoptosis. Physiopathology of BPPV occurs as a result of endolymph flow due to free otoliths escaping from the utricular macula to the semicircular canal [19]. Calcium carbonate constitutes the structure of otoliths. Increasing the amount of free calcium in the endolymph decreases the dissolution of the otolith escaping into the semicircular canal in the endolymph. This increased calcium level by oxidative stress prevents the reabsorption of otoliths escaping to the semicircular canal. Zucca et al. In their study with the frog inner ear, they reported that in order to dissolve the otoconia in the endolymph, the calcium level in the endolymph should be low, and on the contrary, if the calcium in the endolymph increases, the otoconi cannot be resolved. They stated that high calcium provides a long duration of BPPV attack [20]. This fact may contribute to explain the role of increased calcium in the inner ear due to oxidative stress in the pathophysiology of BPPV. In a study, they found that serum vitamin D levels in BPPV patients were significantly lower than in the control group. They suggested that oxidative stress increased and BPPV developed in patients with vitamin D deficiency due to the relationship of vitamin D to Ca metabolism [21]. The fact that vitamin D is directly related to calcium physiology makes our hypothesis strong. However, in our study, we could not measure serum calcium and vitamin D values in our patients due to financial reasons. We think that the increased amount of calcium in the endolymph due to oxidative stress is important in the development of BPPV.

The significant relationship between the concentration of serum oxidative stress markers such as SOD, Native Tyhol, Disulfide and BPPV has been explained [15,17,22,23]. In oxidative stress, thiol oxidized and turns into disulfide. Thiol balance is an important and dual indicator of oxidant-antioxidant balance [10]. Thiol / disulfide homeostasis (TDH) has an important role in antioxidant processes, cell growth and apoptosis [10,24]. It is thought that the imbalance in TDH plays a role in the pathogenesis of diseases through oxidative stress and tissue inflammation. In the literature, the effect of TDH in many diseases such as sudden sensorineural hearing loss, vitiligo, Hashimoto thyroiditis, and polycystic ovary syndrome has been investigated [25,26]. In studies with patients with coronary atherosclerosis, it was found that the severity of atherosclerosis increased in patients with low serum NT/disulfide ratio [27]. Low NT levels were found to be significantly associated with the disease in the patient group diagnosed with nasal polyposis [28]. However, there are very few studies on BPPV and TDH in the literature. Şahin E. et al. found significantly lower SH and high SD rates during an attack. They also found lower NT levels, lower NT / TT ratio and higher disulfide levels in patients with BPPV in the control blood [23]. Li et al. found high SOD level after the vertigo attack [18]. With the support of these findings, the relationship between oxidative stress and BPPV attack is significant. In our study, we found significantly lower NT level, lower NT / TT ratio and higher disulfide level in the BPPV group compared to the control group during the attack (p <0.05). Although native thiol elevation appears to be a risk factor for vertigo in ROC analysis native thiol is a part of the thiol-disulphide balance. For this reason, it would be more appropriate to evaluate the balance in its entirety. When we look at the comparison between the groups, it is seen that the disulfide levels, which can be an indicator of the relevant balance, are lower in the control group. As a result, when the thiol-disulphide balance is considered, high disulphide levels appear as a risk factor for vertigo. These findings were consistent with the literature.

Antioxidants prevent the formation of reactive oxygen species and prevent the damage caused by these substances and provide detoxification. Antioxidants prevent the progression of autooxidation by reacting rapidly with radicals [10]. Zn and Cu, which are cofactors in many metalloenzymes, are also very powerful antioxidants and they are essential elements for antioxidation. Superoxide dismutase (SOD), an antioxidant enzyme, contains Zn and Cu in its structure. Superoxide, the substrate of SOD, reacts with fatty acids in the membranes to form products such as malondialdehyde (MDA) and 4 hydroxy nonenal. These are mutagenic and cellular destructive toxins [18]. Serum Zn and Cu values can give information about antioxidant capacity. Low serum Cu and Zn may contribute to the development of BPPV, as it will reduce the antioxidant capacity. There is no previous research in the literature to explain the relationship between Cu/Zn and vertigo. In our study Cu levels were significantly lower in the BPPV group compared to the control group (p <0.05). This low level supports our hypothesis that the SOD enzyme increases free radical formation by decreasing its activity and that it triggers BPPV as a result of oxidative stress and Ca metabolism. However, the Zn level was lower in the control group, and this result was not suitable for our hipotesis. Our research results, which show a very positive, strong and statistically significant correlation between Cu and Total Thiol and Native Thiol variables, support the thiol and copper differences between the groups (Tables 5 and 6).

Table 5. Pearson correlation matrix of trace elements and oxidation products for control group.

Variables Zn Cu
Total Thiol r = 0.2158
p = 0.082
r = 0.9049
p = <0.001
Native Thiol r = 0.2068
p = 0.096
r = 0.8367
p = <0.001
Disulfide r = -0.0065
p = 0.959
r = 0.073
p = 0.560
Reduced Thiol r = 0.0934
p = 0.456
r = 0.2015
p = 0.105
Oxidized Thiol r = -0.0871
p = 0.487
r = -0.1961
p = 0.115
Thiol Oxidation / Reduction Ratio r = 0.0081
p = 0.949
r = 0.047
p = 0.708

The top side of the matrix is the pearson correlation coefficient (r) and the bottom side is the significance value (p).

If the increase in oxidative stress cannot be suppressed by the antioxidant capacity, then the damage caused by free radicals begins to increase. The resulting free radical damage may trigger the formation of diseases in cells, tissues and organs. Thus, it has been previously s-hown that oxidative damage plays a role in the formation of more than one hundred serious diseases [1418]. Considering our research results, thiol-disulphide balance, which is a strong bidirectional indicator of antioxidant capacity and oxidative stress, can also be considered as a good clinical laboratory marker for BPPV. The increase in disulphide and decrease in thiol seem to be possible parts of a biochemical mechanism that triggers the formation of BPPV.

The limitations of our study were the small number of patients ane the one time blood sample was taken from the patients. Blood samples were taken from the patients only one time and it was during the attack, We did not check the control blood after the attack. We also could not measure serum calcium and vitamin D levels. Measuring the serum calcium and vitamin D values could have helped us to interpret the pathophysiology of BPPV more clearly. However, we had to limit our work due to financial inadequacies.In addition, due to the covid-19 pandemic that affected the whole world, a high number of patients could not be established in our study due to the limitation of hospital admissions for non-covid-19 reasons.

Conclusion

As a result, low Cu and Zn levels decrease the antioxidant activity and increase the formation of BPPV. Serum oxidative stress and trace elements play a role in the pathophysiology of BPPV. We believe that serum trace elements and Thiol-disulfide homeostasis may be a possible laboratory indicator in BPPV. We present the cut-off values for Cu and Zn in vertigo patients for the first time in the literature. We think that these cut-off values of the trace elements and thiol/disulfide hemostasis can be used clinically by physicians in the etiology, diagnosis and treatment of vertigo. We suggest researchers to emphasize these results more strongly with the findings of a higher number of patients and samples.

Supporting information

S1 File

(XLSX)

S2 File

(DOCX)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Moulin T, Sablot D, Vidry E, Belahsen F, Berger E, Lemounaud P et al. Impact of emergency room neurologists on patient management and outcome. Eur Neurol. 2003;50(4):207–14. doi: 10.1159/000073861 [DOI] [PubMed] [Google Scholar]
  • 2.Chu Y-T, Cheng L. Vertigo and dizziness. Acta Neurol Taiwan. 2007;16(1):50–60. [PubMed] [Google Scholar]
  • 3.Balatsouras DG, Ganelis P, Korres G, Kaberos A. Diagnosis of single- or multiple-canal benign paroxysmal positional vertigo according to the type of nystagmus. Int. J. Otolaryngol. 2011, 483965, doi: 10.1155/2011/483965 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Liu Y, Wang W, Zhang AB, Bai X, Zhang S. Epley and Semont maneuvers for posterior canal benign paroxysmal positional vertigo: A network meta-analysis. Laryngoscope. 2016; 126: 951–5. doi: 10.1002/lary.25688 [DOI] [PubMed] [Google Scholar]
  • 5.Fay JL. Benign Paroxysmal Positional Vertigo in 2 Children: A Case Series. Pediatr Phys Ther. 2016; 28: 355–60. doi: 10.1097/PEP.0000000000000249 [DOI] [PubMed] [Google Scholar]
  • 6.Sato H, Shibata H, Shimizu T, Shibata S, Toriumi H, Ebine T. Differential cellular localization of antioxidant enzymes in the trigeminal ganglion. Neuroscience. 2013; 248:345–358. doi: 10.1016/j.neuroscience.2013.06.010 [DOI] [PubMed] [Google Scholar]
  • 7.Navarro-Yepes J, Zavala-Flores L, Anandhan A, Wang F, Skotak M, Chandra N. Antioxidant gene therapy against neuronal cell death. Pharmacology & Therapeutics, 2014;142:206–230. doi: 10.1016/j.pharmthera.2013.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Baba S. P, Bhatnagar A. Role of thiols in oxidative stress. Current Opinion in Toxicology. 2018; 7:133–139. doi: 10.1016/j.cotox.2018.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V. et al. Oxidative Stress: Harms and Benefits for Human Health. Oxidative Medicine and Cellular Longevity. 2017; 1–13. doi: 10.1155/2017/8416763 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Erel O, Neselioglu S. A novel and automated assay for thiol/ disulphide homeostasis. Clin Biochem. 2014; 47:326–332. doi: 10.1016/j.clinbiochem.2014.09.026 [DOI] [PubMed] [Google Scholar]
  • 11.Mahajan A, Tandon V.R. Antioxidants and rheumatoid arthritis. Journal of Indian Rheumatology Association, 2004; 139–142. [Google Scholar]
  • 12.Gao F, Kinnula VL, Myllärniemi M, Oury TD. Extracellular Superoxide Dismutase in Pulmonary Fibrosis. Antioxid Redox Signal. 2008; 10(2): 343–354. doi: 10.1089/ars.2007.1908 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Homsher R, Zak B. Spectrophotometric Investigation of Sensitive Complexing Agents for the Determination of Zinc in Serum. Clin Chem. 1985;31(8):1310–3. doi: 10.1093/CLINCHEM/31.8.1310 [DOI] [PubMed] [Google Scholar]
  • 14.El-Masry HMA, Sadek AA, Hassan MH, Ameen HH, Ahmed HA. Metabolic profile of oxidative stress and trace elements in febrile seizures among children. Metab Brain Dis. 2018;33(5):1509–1515. doi: 10.1007/s11011-018-0258-7 [DOI] [PubMed] [Google Scholar]
  • 15.Güçlütürk MT, Ünal ZN, İsmi O, Çimen MB, Ünal M. The Role of Oxidative Stress and Inflammatory Mediators in Benign Paroxysmal Positional Vertigo. J Int Adv Otol. 2016;12:101–5. doi: 10.5152/iao.2015.1412 [DOI] [PubMed] [Google Scholar]
  • 16.Ulusoy S, Ayan NN, Dinc ME, Is A, Bicer C, Erel O. A new oxidative stress marker for thiol-disulphide homeostasis in seasonal allergic rhinitis. Am J Rhinol Allergy. 2016; 30: 53–7. doi: 10.2500/ajra.2016.30.4308 [DOI] [PubMed] [Google Scholar]
  • 17.Tsai K L, Cheng Y Y, Leu H, Lee Y Y, Lan C. Investigating the role of Sirt1-modulated oxidative stress in relation to benign paroxysmal positional vertigo and Parkinson’s disease. Neurobiol. Aging. 2015;36: 2607–2616. doi: 10.1016/j.neurobiolaging.2015.05.012 [DOI] [PubMed] [Google Scholar]
  • 18.Li J, Wu R, Xia B, Wang X, Xue M. Serum levels of superoxide dismutases in patients with benign paroxysmal positional vertigo. Bioscience Reports. 2020;40(5):BSR20193917. doi: 10.1042/BSR20193917 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Parnes LS, Mcclure JA. Free‐floating endolymph particles: a new operative finding during posterior semicircular canal occlusion. The Laryngoscope. 1992; 102: 988–992. doi: 10.1288/00005537-199209000-00006 [DOI] [PubMed] [Google Scholar]
  • 20.Zucca G, Valli S, Valli P, Perin P, Mira E. Why do benign paroxysmal positional vertigo episodes recover spontaneously? J Vestib Res 8 (1998), 325–329. [PubMed] [Google Scholar]
  • 21.Talaat HS, Abuhadied G, Talaat AS, Abdelaal MS. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol. 2015;272(9):2249–53. doi: 10.1007/s00405-014-3175-3 Epub 2014 Jun 29. [DOI] [PubMed] [Google Scholar]
  • 22.Qian S X, Gu J X, Guan Q B, Zhang XL, Wang YP. Serum oxidative stress, inflammatory response and platelet activation in patients with vascular vertigo. J. Biol. Regul. Homeost. Agents. 2019; 33: 499–504. [PubMed] [Google Scholar]
  • 23.Şahin E, Deveci İ, Dinç M.E, Özker B.Y, Biçer C, Erel Ö. Oxidative status in patients with benign paroxysmal positional vertigo. J. Int. Adv. Otol. 2018;14:299–303. doi: 10.5152/iao.2018.4756 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jones DP, Liang L. Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med. 2009;47(10):1329–38. doi: 10.1016/j.freeradbiomed.2009.08.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem. 1993;26:351–7. doi: 10.1016/0009-9120(93)90111-i [DOI] [PubMed] [Google Scholar]
  • 26.Kundi H, Erel Ö, Balun A, Çiçekçioğlu H, Cetin M, Kiziltunç E et al. Association of thiol/disulfide ratio with syntax score in patients with NSTEMI. Scandinavian Cardiovascular Journal 2015; 49: 95–100. Scand Cardiovasc J. 2015 Apr;49(2):95–100. doi: 10.3109/14017431.2015.1013153 Epub 2015 Mar 2. [DOI] [PubMed] [Google Scholar]
  • 27.Kundi H, Ates I, Kiziltunc E, Cetin M, Cicekcioglu H, Neselioglu S et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015. Nov;33(11):1567–71. doi: 10.1016/j.ajem.2015.06.016 Epub 2015 Jun 14. . [DOI] [PubMed] [Google Scholar]
  • 28.Simsek E, Erel O, Bicer CK, Carlioglu A. A novel method for determining the relation between nasal polyposis and oxidative stress: the thiol/disulphide homeostasis. Acta Oto-Laryngololica. 2016; Nov;136(11):1180–1183. doi: 10.1080/00016489.2016.1186833 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Nicolás Pérez-Fernández

13 Feb 2022

PONE-D-21-36104An Evaluation of Trace Elements and Oxidative Stress in Patients With Benign Paroxysmal Positional VertigoPLOS ONE

Dear Dr. gunizi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 30 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Nicolás Pérez-Fernández

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please ensure that you include a title page within your main document. We do appreciate that you have a title page document uploaded as a separate file, however, as per our author guidelines (http://journals.plos.org/plosone/s/submission-guidelines#loc-title-page) we do require this to be part of the manuscript file itself and not uploaded separately.

3. Thank you for stating the following financial disclosure:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

At this time, please address the following queries:

a)        Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b)        State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c)        If any authors received a salary from any of your funders, please state which authors and which funders.

d)        If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this study, the authors have attempted to determine the role of thiol/disulfide homeostasis as a novel marker of oxidative stress in BPPV.

Although the study is interesting and presents some novel information that deserve to be highlighted, it is necessary to make some changes in the text detailed below:

-Level of evidence must be changed to II-2.

-Introduction: It would be advisable for the authors to further develop the concepts related to oxidative stress and chronic inflammatory diseases already described in the literature. Besides, more bibliography should be provided on the antioxidant effect of the trace elements Cu and Zn.

-Materials and Methods: The selection of patients should include in more detail at what time of the attack the analytical blood extraction was performed and above all, it would be very important to know if in the inclusion criteria, the patients were carried out an analytical study that allows to know if there is a basal inflammatory disease (erythrocyte rate sedimentation, Reactive Protein C, etc ...), in order to rule out from the sample an associated systemic disorders. Furthermore, Erel et al have described association between high levels disulphide values in plasma of smoking, diabetic and obesity patients.

Measurement of Thiol and Disulphide homeostasis, the text must be improved because in Tables: Reduced Thiol, oxidized thiol and thiol oxidation/reduction ratio are showed.

-statistical analysis: In the non-parametric study of the means by means of the Mann U test, I understand that it would be advisable to add the Bonferroni correction and if it is not necessary it should be expressed in the text.

-Results: The text: "The risk of developing BPPV in patients with serum NT level higher than 416.5 μmol/L was 85,615 times higher than those with serum NT level lower than 416.5 μmol/L (Odds ratio: 85.615 %95 CI :23.160-316.499 P<0.001)."

Reviewing Table 4, I understand that it is an error since in the table it is expressed that values lower than 416.5 are those that are associated with an odds ratio 85,615 times higher than those with values higher than that figure.

Dscussion:The authors discuss the possible role of oxidative stress in calcium and vitamin D metabolism but in the Material and Methods of the present series have not led to any studies related to it. This topic must be explained or put into limitations of the study.

Limitations should be extended in the corresponding final section

Reference 20. could be completed with another by Kundi H, Ates I, Kiziltunc E, Cetin M, Cicekcioglu H, Neselioglu S, Erel O, Ornek E. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015 Nov;33(11):1567-71. doi: 10.1016/j.ajem.2015.06.016. Epub 2015 Jun 14. PMID: 26143314.

In Table 3, it is expressed that the elements Zn and Cu, as well as the total thiol show values lower than 0.75 in the area under the ROC curve, and this finding must be interpreted as being a regular test or perhaps not completely adequate to detect what the authors are looking for. In addition, it is necessary that the values are expressed in a new Figure in order to graphically assess the results of the ROC curve.

Reviewer #2: Dear authors, congratulations for your research!

There are some corrections and clarifications, that I would like to propose:

1.in the abstract> abbreviation for BPPV not BPVV

2. Introduction> instead of "BPPV occurs as a result of endolymph flow that occurs due to the free movement.." Better, BPPV is ascribed to otoconial matter dislodged from utricular macula and attached to the cupula of the affected semicircular canal (cupulolithiasis) or free-floating within its lumen (canalolithiasis).

3. Material and Methods > Epley's maneuver was performed for the posterior SCC-BPPV, Ok . How about the lateral SCC BPPV ? What is the percentage of SCC affected ? please clarify

4. results> Is there any difference of Cu level between gender in your study group? please clarify

5. Discussion > This article "G. Zucca, S. Valli, P. Valli, P. Perin and E. Mira, Why do benign paroxysmal positional vertigo episodes recover spontaneously? J Vestib Res 8 (1998), 325–329." show us that is pivotal the calcium concentration in that patients. Did you measure ?

TDD > what does it mean?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Feb 22;18(2):e0277960. doi: 10.1371/journal.pone.0277960.r002

Author response to Decision Letter 0


13 Apr 2022

Reviewer 1 Comments and Author’s answer:

-Level of evidence must be changed to II-2.

The specified adjustment has been made.

-Introduction: It would be advisable for the authors to further develop the concepts related to oxidative stress and chronic inflammatory diseases already described in the literature. Besides, more bibliography should be provided on the antioxidant effect of the trace elements Cu and Zn.

Introduciton updated with new references

‘’Oxidative stress is a condition caused by an imbalance between production and accumulation of oxygen reactive species (ROS) in cells or tissues and the ability of a biological system to detoxify these reactive products.(yeni1) Superoxide radicals, hydrogen peroxide, hydroxyl radicals and singlet oxygen are commonly defined reactive oxygen species (ROS).6-7 In the tissues, high rates of oxygen utilization lead to the generation of partially reduced forms of oxygen or reactive oxygen species (ROS), which are derived from the activity of electron transport chain in mitochondria.8 Free radicals cause oxidative cell damage and this is a situation that occurs continuously during metabolic processes. ROS and free radicals react with and damage several cellular structures such as proteins, lipids, membranes, lipoproteins, and deoxyribonucleic acid.9 ROS react with most biomolecules, their major targets include unsaturated lipids and intracellular thiols.8 In oxidative stress, thiol oxidizes and converts to disulfide. Thiol balance is an important and dual indicator of oxidant-antioxidant balance.10 Prevention of oxidative damage, keeping it in balance and maintaining vitality is only possible with antioxidant activity. If this process gets out of control it can induces several chronic inflammatory diseases as rheumatoid arthritis, and degenerative, body aging process and acute pathologies as stroke.9,11

Trace elements constitute the building blocks of enzymes, hormones and vitamins as well as metabolism support, healthy tissue formation and supporting the immune system. Zn and Cu are the trace elements that are essential and vital for the body. Zinc is an enzymatic activator and catalyst in hormonal processes and amino acid cycle. Copper is a necessary trace element in the controlled work of enzymes in biological oxidation events. The extracellular form of the superoxide dismutase enzyme, which is the only antioxidant secreted by fibroblast, glia and endothelial cells and capable of inactivating superoxide radicals enzymatically at the extracellular level, contains Cu and Zn. It has a very important role in the prevention of many diseases such as oxidant damage, inflammation and fibrosis.12 Therefore, the antioxidant effect of Zn and Cu is remarkable.’’

-Materials and Methods: The selection of patients should include in more detail at what time of the attack the analytical blood extraction was performed and above all, it would be very important to know if in the inclusion criteria, the patients were carried out an analytical study that allows to know if there is a basal inflammatory disease (erythrocyte rate sedimentation, Reactive Protein C, etc ...), in order to rule out from the sample an associated systemic disorders.

The criteria for inclusion and exclusion from the study were more clearly stated.

‘’Dix-Hallpike and Supine Head-Roll maneuvers were performed. Epley's and Barbecue repositioning maneuver was applied to patients who developed rotatory nystagmus during the maneuvers and supported BPVV. Among these patients, those who did not have diabetes mellitus, hyperlipidemia, etc., had normal parameters such as sedimentation and c-reactive protein in routine blood tests, and had a first BPPV attack were included in the study. Blood samples were taken from patients diagnosed with BPVV to measure serum Zn and Cu levels and oxidative stress levels during at the first attack and before 12:00 a.m. while they were fasting. The control group included 66 healthy volunteers with age and gender distribution similar to the BPPV patient group. They had no neurotologic symptoms and no history of any dizziness or imbalance.’’

Measurement of Thiol and Disulphide homeostasis, the text must be improved because in Tables: Reduced Thiol, oxidized thiol and thiol oxidation/reduction ratio are showed.

The measurement of Thiol and Disulfide homeostasis has been clarified more clearly.

‘’Thiol / disulfide homeostasis measurements were made using the standard colorimetric method described in the literature.10 Two separate serum samples were collected for each patient. Serum total thiol measurement was performed using standard colorimetric method and commercial kit (Rel Assay Diagnostics, Gaziantep). Ten µL sample was treated with 10µL sodium borohydride in 50% methanol-water solution (v/v; R1). 110µL 6.715mM formaldehyde and 10.0mM ethylenediaminetetraacetic acid (EDTA) in Tris buffer 100mM (pH 8.2) used for Excess reductants eliminating to determine total thiol. A 10µL sample was treated with 10µL sodium chloride in 50% methanol-water solution (v/v; R1’) and 110µL 6.715mM formaldehyde and 10.0mM EDTA in Tris buffer 100mM (pH 8.2) used to determine native thiol. Dynamic disulfide amount was calculated by taking half of the difference between the total thiol and natural thiol groups. All the chemicals were purchased from Merck Chemicals (Darmstadt, Germany) and Sigma-Aldrich Chemie (Milwaukee, Wisconsin, USA). In this way, natural and total thiols were calculated. Then serum disulfide levels and disulfide / natural thiol, disulfide / total thiol and natural / total thiol ratios were determined. Units are given as μmol/L .10’’

-statistical analysis: In the non-parametric study of the means by means of the Mann U test, I understand that it would be advisable to add the Bonferroni correction and if it is not necessary it should be expressed in the text.

Since we only looked at 2 parameters, Bonferroni correction was not applied and this material method was also specified.

-Results: The text: "The risk of developing BPPV in patients with serum NT level higher than 416.5 μmol/L was 85,615 times higher than those with serum NT level lower than 416.5 μmol/L (Odds ratio: 85.615 %95 CI :23.160-316.499 P<0.001)."

Reviewing Table 4, I understand that it is an error since in the table it is expressed that values lower than 416.5 are those that are associated with an odds ratio 85,615 times higher than those with values higher than that figure.

The wrong in the sentence was understood and corrected.

‘’The risk of developing BPPV in patients with serum NT level lower than 416.5 μmol/L was 85,615 times higher than those with serum NT level higher than 416.5 μmol/L (Odds ratio: 85.615 %95 CI :23.160-316.499 P<0.001).’’

Dscussion:The authors discuss the possible role of oxidative stress in calcium and vitamin D metabolism but in the Material and Methods of the present series have not led to any studies related to it. This topic must be explained or put into limitations of the study.

Calcium and vitamin D were used in the discussion because of their association with oxidative stress and BPVV. This topic has been explained and discussed in more detail.

Limitations should be extended in the corresponding final section

Limitations extended

‘’The limitations of our study were the small number of patients ane the one time blood sample was taken from the patients. Blood samples were taken from the patients only one time and it was during the attack, We did not check the control blood after the attack. We also could not measure serum calcium and vitamin D levels. Measuring the serum calcium and vitamin D values could have helped us to interpret the pathophysiology of BPVV more clearly. However, we had to limit our work due to financial inadequacies.In addition, due to the covid-19 pandemic that affected the whole world, a high number of patients could not be established in our study due to the limitation of hospital admissions for non-covid-19 reasons.’’

Reference 20. could be completed with another by Kundi H, Ates I, Kiziltunc E, Cetin M, Cicekcioglu H, Neselioglu S, Erel O, Ornek E. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015 Nov;33(11):1567-71. doi: 10.1016/j.ajem.2015.06.016. Epub 2015 Jun 14. PMID: 26143314.

Corrections stated by the referee in the reference section were made.

In Table 3, it is expressed that the elements Zn and Cu, as well as the total thiol show values lower than 0.75 in the area under the ROC curve, and this finding must be interpreted as being a regular test or perhaps not completely adequate to detect what the authors are looking for.

This was highlighted in the results.

‘’ In the ROC analysis of Cu, Zn and Total Thiol values, the AUC values were below 0.75, so we could not evaluate these values as independent predictive factors.’’

In addition, it is necessary that the values are expressed in a new Figure in order to graphically assess the results of the ROC curve.

Added a figure showing the ROC curve.

Reviewer 2’s comments and Author’s answers:

1.in the abstract> abbreviation for BPPV not BPVV

Changed the abbreviation BPVV to BPPV in the summary section.

2. Introduction> instead of "BPPV occurs as a result of endolymph flow that occurs due to the free movement.." Better, BPPV is ascribed to otoconial matter dislodged from utricular macula and attached to the cupula of the affected semicircular canal (cupulolithiasis) or free-floating within its lumen (canalolithiasis).

The previous sentence, the specified sentence has been changed.

3. Material and Methods > Epley's maneuver was performed for the posterior SCC-BPPV, Ok . How about the lateral SCC BPPV ? What is the percentage of SCC affected ? please clarify

This sentence has been added to the results ‘’There were 54 (82%) patients with BPPV affecting the posterior and 12(18%) patients with BPPV affecting the lateral canal’’

4. results> Is there any difference of Cu level between gender in your study group? please clarify

This sentence has been added to the results ‘’There were no statistically significant differences between male and female genders in terms of Cu and Zn levels.’’

5. Discussion > This article "G. Zucca, S. Valli, P. Valli, P. Perin and E. Mira, Why do benign paroxysmal positional vertigo episodes recover spontaneously? J Vestib Res 8 (1998), 325–329." show us that is pivotal the calcium concentration in that patients. Did you measure ?

This subject was discussed again by adding the mentioned article and the subject was clarified.

‘’ Zucca et al. In their study with the frog inner ear, they reported that in order to dissolve the otoconia in the endolymph, the calcium level in the endolymph should be low, and on the contrary, if the calcium in the endolymph increases, the otoconi cannot be resolved. They stated that high calcium provides a long duration of BPVV attack.20 This fact may contribute to explain the role of increased calcium in the inner ear due to oxidative stress in the pathophysiology of BPPV. In a study, they found that serum vitamin D levels in BPPV patients were significantly lower than in the control group. They suggested that oxidative stress increased and BPVV developed in patients with vitamin D deficiency due to the relationship of vitamin D to Ca metabolism.21 The fact that vitamin D is directly related to calcium physiology makes our hypothesis strong. However, in our study, we could not measure serum calcium and vitamin D values in our patients due to financial reasons. We think that the increased amount of calcium in the endolymph due to oxidative stress is important in the development of BPVV.’’

TDD > what does it mean?

It was noticed that TDD was written incorrectly instead of TDH (Thiol / disulfide homeostasis ) and it was corrected.

Attachment

Submitted filename: answer letter to reviewers .docx

Decision Letter 1

Emre Avci

5 Aug 2022

PONE-D-21-36104R1An Evaluation of Trace Elements and Oxidative Stress in Patients With Benign Paroxysmal Positional VertigoPLOS ONE

Dear Dr. gunizi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 09 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Emre Avci

Academic Editor

PLOS ONE

Additional Staff Editor comments: We noted your manuscript is similar to this published work https://pubmed.ncbi.nlm.nih.gov/30256204/. Please note that our policy requires that related works must be discussed and justifications should be provided in terms of the differences  and what contributions you study make to the community. Please discuss this related work in more details.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: For me, all the requirements that have been requested have been met. The authors must go back to review the writing in case there is any more writing error.

Reviewer #3: An evaluation of trace elements and oxidative stress in patients with benign paroxysmal positional vertigo.

Authors resulted that low Cu and Zn levels decrease the antioxidant activity and increase the formation of BPPV and serum oxidative stress and trace elements play a role in the pathophysiology of BPPV. Outcomes of the present study would provide useful information for readers. However, data presentation is insufficient for acceptance without revision. The manuscript needs to be revised in the followings.

#Patients with a history of Meniere's disease, vestibular neuritis, acoustic neurinoma, sudden hearing loss, hearing loss on audiometric examination, history of head trauma, and having an otologic surgery were not included in the study.

It is said that MD and SD are caused by stress, too. Why did you exclude these diseases?

If you conclude that the onset of BPPV is due to a decrease in Cu and Zn, isn’t it necessary to compare BPPV and other vertiginous diseases?

Overdose of Zn over a long period of time reduces Cu absorption. Therefore, it may be a physiological reaction. How about this physiological reaction?

#Serum Zn and Cu values can give information about antioxidant capacity. Low serum Cu and Zn may contribute to the development of BPPV.

The relationship between changes in serum Zn and Cu levels and oxidative stress due to vitamin D deficiency is unclear. To compare the article, authors should provide actual data on this relationship.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Juan Carlos Amor-Dorado, MD, PhD

Reviewer #3: Yes: Hiroshi Inui, M.D., Ph.D.

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: review result 1.docx

PLoS One. 2023 Feb 22;18(2):e0277960. doi: 10.1371/journal.pone.0277960.r004

Author response to Decision Letter 1


10 Aug 2022

Response to Reviewers

*Additional Staff Editor comments: We noted your manuscript is similar to this published work https://pubmed.ncbi.nlm.nih.gov/30256204/. Please note that our policy requires that related works must be discussed and justifications should be provided in terms of the differences and what contributions you study make to the community. Please discuss this related work in more details.

This article was mentioned in the discussion of our previous article. but it was mentioned in more detail on your suggestion.

‘’ However, there are very few studies on BPPV and TDH in the literature. Şahin E. et al. found significantly lower SH and high SD rates during an attack. Their study is similar to our study but our study is more comprehensive and valuable due to the large number of patients and the fact that we have measured zinc and copper (23). In addition, the results of Şahin et al.'s study are consistent with the results of our study and support our findings..’’

**#Patients with a history of Meniere's disease, vestibular neuritis, acoustic neurinoma, sudden hearing loss, hearing loss on audiometric examination, history of head trauma, and having an otologic surgery were not included in the study. It is said that MD and SD are caused by stress, too. Why did you exclude these diseases?

If you conclude that the onset of BPPV is due to a decrease in Cu and Zn, isn’t it necessary to compare BPPV and other vertiginous diseases?

It is known that endolymphatic hydrops rather than stress has a role in the etiology of Meniere's disease. this is far from the etiology of BPVV. In addition, since the etiologies of MD and SD were different from BPVV, these patients were evaluated within the differential diagnosis.

***If you conclude that the onset of BPPV is due to a decrease in Cu and Zn, isn’t it necessary to compare BPPV and other vertiginous diseases?

The onset of BPPV is associated with the decrease in Cu and Zn. Comparison of BPPV with other vertigo diseases can be made with additional and new studies. It may be suggested in the discussion to make new measurements to see if there is the same situation in diseases with similar etiology.

****Overdose of Zn over a long period of time reduces Cu absorption. Therefore, it may be a physiological reaction. How about this physiological reaction?

An overdose of Zn over a long period of time reduces Cu absorption. Therefore, copper may be low as a result of a physiological reaction. However, the low levels of zinc and copper in our study do not match the physiological picture. In addition, there was no use of high-dose zinc in our study.

*****#Serum Zn and Cu values can give information about antioxidant capacity. Low serum Cu and Zn may contribute to the development of BPPV. The relationship between changes in serum Zn and Cu levels and oxidative stress due to vitamin D deficiency is unclear. To compare the article, authors should provide actual data on this relationship.

In the study conducted by Socha et al., the decrease in zinc and Total antioxidant status in Alzheimer's patients compared to the control group also supports our study results (2) However, in our study, we could not measure serum calcium and vitamin D values in our patients due to financial reasons. And this topic was mentioned in the article.

1. Şahin E, Deveci İ, Dinç ME, Özker BY, Biçer C, Erel Ö. Oxidative Status in Patients with Benign Paroxysmal Positional Vertigo. J Int Adv Otol. 2018 Aug;14(2):299-303. doi: 10.5152/iao.2018.4756.

2. Socha K, Klimiuk K, Naliwajko SK, Soroczyńska J, Puścion-Jakubik A, Markiewicz-Żukowska R, Kochanowicz J. Dietary Habits, Selenium, Copper, Zinc and Total Antioxidant Status in Serum in Relation to Cognitive Functions of Patients with Alzheimer's Disease. Nutrients. 2021 Jan 20;13(2):287. doi: 10.3390/nu13020287.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Donovan Anthony McGrowder

8 Nov 2022

An Evaluation of Trace Elements and Oxidative Stress in Patients With Benign Paroxysmal Positional Vertigo

PONE-D-21-36104R2

Dear Dr. Gunizi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Donovan Anthony McGrowder, PhD., MA., MSc

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear Dr. Gunizi,

The manuscript entitled “An Evaluation of Trace Elements and Oxidative Stress in Patients With Benign Paroxysmal Positional Vertigo” was revised in accordance with the reviewers’ comments and is provisionally accepted pending final checks for formatting and technical requirements.

Regards,

Dr. Donovan McGrowder (Academic Editor)

Acceptance letter

Donovan Anthony McGrowder

10 Nov 2022

PONE-D-21-36104R2

An Evaluation of Trace Elements and Oxidative Stress in Patients With Benign Paroxysmal Positional Vertigo

Dear Dr. gunizi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Donovan Anthony McGrowder

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (XLSX)

    S2 File

    (DOCX)

    Attachment

    Submitted filename: answer letter to reviewers .docx

    Attachment

    Submitted filename: review result 1.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES